Two pathways, the focal adhesion kinase (FAK)/Pl3K-Akt signaling pathway and JAK-STAT signaling pathway, were uniquely identified in S:E fusion-positive prostate cancer. This evidence concerns the gene PTK2 and prostate carcinoma.